The Jenner Institute is a research partnership between the University of Oxford and The Pirbright Institute.
The Institute focuses on the parallel development of human and veterinary vaccines against major global diseases - from early-stage research through to clinical trials.
03:00 PM 15 July, Saïd Business School, Oxford
Join us for what is certain to be an informative and enthralling discussion about how entrepreneurs, academics, industry professionals and governments can learn lessons from the collaborative approach used to fight Ebola, and how this can lead to revolutionary new approaches in drug discovery & development.
LONDON, June 15 (Reuters) - Three years after the mysterious MERS virus first emerged in humans, scientists and drugmakers say there is no excuse for not having a vaccine that could have protected those now falling sick and dying in South Korea. "The question is: How long are we going to wait around and just follow these outbreaks before we get serious about making vaccines?" said Adrian Hill, a professor and director at the Jenner Institute at Britain's Oxford University.
Prof Peter Crompton (Malaria Infection Biology and Immunity Unit, NIAID): Unravelling the cellular and molecular basis of naturally acquired immunity to malaria, 03 Aug 12:00
The identification of a killer cell immunoglobulin-like receptor 3DL1*0150209 in an Asian population using molecular techniques. Tissue Antigens
Searching for the human genetic factors standing in the way of universally effective vaccines. Philos Trans R Soc Lond B Biol Sci , 370 (1671)
Clinical trials are an essential part of vaccine development, and our volunteers play a critical role in our studies.
If you would like to find out more about paid clinical trials, and what is involved in participating, please go to our Recruiting Trials page to see which trials are currently recruiting.